Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00558792 · ClinicalTrials.gov registry record · Phase 2
Coronary MDCTA With Iopamidol Injection 370
A Phase 2 study, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- Phase 2
- Development phase
- 210
- Enrollment target
NCT00558792: Completed Phase 2 study, sponsored by Bracco Diagnostics.
NCT00558792 is a Phase 2 study that has completed, run by Bracco Diagnostics. The registered enrollment target is 210 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (58% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00558792, a Phase 2 study, has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 210 participants
- Enrollment target
Study Summary
Determine the validity and compare the visualization of arterial segments obtained with 3 doses of iopamidol to determine dose for further investigation in future trials.
Primary Outcome
For all technically adequate coronary artery segments, each reader was to assess whether each segment was visualized to a quality that was adequate for accurate diagnosis of the presence and severity of stenosis. An adequate quality for the accurate diagnosis of the presence and severity of coronary artery stenosis was comprised of 2 basic features: 1) no more than mild blurring of the spatial distinction between the vessel wall and lumen, and 2) a readily visible distinction in image contrast b
Interventions
- DRUG Isovue 370, 70 mL
- DRUG Isovue 370, 80 mL
- DRUG Isovue 370, 90 mL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
What the finished NCT00558792 record still lists
NCT00558792 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (58% higher).
The record links to 0 conditions, and to 3 interventions - of which Isovue 370, 70 mL is the first listed.
NCT00558792 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00558792 about?
NCT00558792 is a clinical study titled "Coronary MDCTA With Iopamidol Injection 370". Determine the validity and compare the visualization of arterial segments obtained with 3 doses of iopamidol to determine dose for further investigation in future trials.
What is the current status of trial NCT00558792?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 210 participants. The study started on 2007-11. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00558792?
The interventions under investigation include: Isovue 370, 70 mL (DRUG), Isovue 370, 80 mL (DRUG), Isovue 370, 90 mL (DRUG).
Who is sponsoring clinical trial NCT00558792?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00558792's enrollment target sits among peer trials
210 290th of 2000 higher than 1,707 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia